SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.985+5.0%3:58 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Magnus1 who wrote (3307)12/10/2014 2:32:13 PM
From: donpat  Read Replies (3) of 12871
 
Re: Questions from an SI faithful fan

EUGENE SEYMOUR
2:25 PM (0 minutes ago)

to me

Eugene Seymour, MD MPH
Chief Executive Officer
NanoViricides, Inc
310-486-5677
A New York Stock Exchange Company

Sent from my iPad

On Dec 10, 2014, at 1:22 PM, I wrote:

Dear Gene;

Just passing on some questions:
Doc... Could you ask him about 1) the USAMRID start date for the Ebolacide 11 testing....does he have a date NNVC is to deliver the CIDES, or do they just call him and say we can take receipt on this specific date?
They will call and say ship and we will
And with 2) Flucide, will BASI release a report when they complete the small animal testing with the 200 grams right away?
Report expected end of January
And then proceed with the large animal testing?
Yes
Im trying to understand the reporting/receipt protocol on both CIDES. Or is it confidential at this point?

Once they send us the report, we request permission to publish an abstract. When granted, we announce!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News